{'output': [['Novocure', 'ORG', 'Operate_In', 'Global Oncology Company', 'ORG'], ['Tumor Treating Fields', 'CONCEPT', 'Produce', 'Novocure', 'ORG'], ['Active patients', 'CONCEPT', 'Has', '1,834', 'ECON_INDICATOR'], ['Active patients', 'CONCEPT', 'Increase', '68%', 'ECON_INDICATOR'], ['Preliminary net revenues', 'CONCEPT', 'Has', '$53.7 million', 'ECON_INDICATOR'], ['Preliminary net revenues', 'CONCEPT', 'Increase', '77%', 'ECON_INDICATOR'], ['Fourth quarter 2017', 'EVENT', 'Relate_To', 'Preliminary net revenues', 'CONCEPT'], ['Fourth quarter 2017', 'EVENT', 'Relate_To', 'Active patients', 'CONCEPT'], ['Fourth quarter 2017 financial results', 'EVENT', 'Report', 'Thursday, February 22, 2018', 'DATE'], ['36th Annual J.P. Morgan Healthcare Conference', 'EVENT', 'Participates_In', 'Novocure', 'ORG'], ['Tumor Treating Fields', 'CONCEPT', 'Impact', 'Solid tumor cancers', 'CONCEPT'], ['Tumor Treating Fields', 'CONCEPT', 'Disrupt', 'Cell division', 'CONCEPT'], ['Tumor Treating Fields', 'CONCEPT', 'Inhibit', 'Tumor growth', 'CONCEPT'], ['Tumor Treating Fields', 'CONCEPT', 'Cause', 'Dividing cancer cells to die', 'CONCEPT'], ['Glioblastoma', 'CONCEPT', 'Treated_With', 'Tumor Treating Fields', 'CONCEPT'], ['Non-small cell lung cancer', 'CONCEPT', 'Treated_With', 'Tumor Treating Fields', 'CONCEPT'], ['Pancreatic cancer', 'CONCEPT', 'Treated_With', 'Tumor Treating Fields', 'CONCEPT'], ['Ovarian cancer', 'CONCEPT', 'Treated_With', 'Tumor Treating Fields', 'CONCEPT'], ['Mesothelioma', 'CONCEPT', 'Treated_With', 'Tumor Treating Fields', 'CONCEPT'], ['United States', 'GPE', 'Has', '1,320 active patients', 'CONCEPT'], ['Germany and other EMEA markets', 'GPE', 'Has', '512 active patients', 'CONCEPT'], ['Japan', 'GPE', 'Has', '2 active patients', 'CONCEPT'], ['Prescriptions received', 'CONCEPT', 'Increase', '55%', 'ECON_INDICATOR'], ['Prescriptions received', 'CONCEPT', 'Has', '1,090', 'ECON_INDICATOR'], ['United States', 'GPE', 'Has', '809 prescriptions received', 'CONCEPT'], ['Germany and other EMEA markets', 'GPE', 'Has', '280 prescriptions received', 'CONCEPT'], ['Japan', 'GPE', 'Has', '1 prescription received', 'CONCEPT'], ['FDA', 'ORG/REG', 'Approve', 'U.S. Food and Drug Administration Investigational Device Exemption (IDE)', 'CONCEPT'], ['PANOVA 3 phase 3 pivotal trial', 'EVENT', 'Initiate', 'Locally advanced pancreatic cancer', 'CONCEPT']]}